LEVETIRACETAM SOL. ORAL 100 MG./ML. FCO. C/300 ML. BUTILHIOSCINA 10.00 MG PRINCIPIO ACTIVO: LINACLOTIDA

Description

PRINCIPIO ACTIVO: LINACLOTIDA

un anticuerpo monoclonal indicado para el tratamiento de enfermedades inflamatorias y autoinmunes

Alternativa en pacientes resistentes o intolerantes a crizotinib

DOSIS: 1 ML

LEVETIRACETAM SOL. ORAL 100 MG./ML. FCO. C/300 ML. BUTILHIOSCINA 10.00 MG PRINCIPIO ACTIVO: LINACLOTIDALEVETIRACETAM 100. 00 MG

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy